<?xml version="1.0" encoding="UTF-8"?>
<ref id="cas13513-bib-0006">
 <label>6</label>
 <mixed-citation publication-type="journal" id="cas13513-cit-0006">
  <string-name>
   <surname>O'Connor</surname>
   <given-names>OA</given-names>
  </string-name>, 
  <string-name>
   <surname>Pro</surname>
   <given-names>B</given-names>
  </string-name>, 
  <string-name>
   <surname>Pinter‐Brown</surname>
   <given-names>L</given-names>
  </string-name>, et al. 
  <article-title>Pralatrexate in patients with relapsed or refractory peripheral T‐cell lymphoma: results from the pivotal PROPEL study</article-title>. 
  <source>J Clin Oncol</source>. 
  <year>2011</year>;
  <volume>29</volume>:
  <fpage>1182</fpage>‐
  <lpage>1189</lpage>.
  <pub-id pub-id-type="pmid">21245435</pub-id>
 </mixed-citation>
</ref>
